OMX Nordic 40
2.515,14
PKT
-15,03
PKT
-0,59
%
Werbung
Analysen zu OMX Nordic 40-Werten
Datum | Rating | Analyst | |
---|---|---|---|
12.03.25 | AstraZeneca Buy | UBS AG | |
11.03.25 | Novo Nordisk Buy | Deutsche Bank AG | |
11.03.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
11.03.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
10.03.25 | AstraZeneca Buy | UBS AG | |
10.03.25 | Novo Nordisk Buy | UBS AG | |
10.03.25 | Novo Nordisk Market-Perform | Bernstein Research | |
10.03.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
10.03.25 | Novo Nordisk Market-Perform | Bernstein Research | |
10.03.25 | AstraZeneca Buy | UBS AG | |
07.03.25 | Novo Nordisk Buy | UBS AG | |
07.03.25 | Hennes Mauritz (H M, H&M) Neutral | UBS AG | |
04.03.25 | Novo Nordisk Buy | Deutsche Bank AG | |
04.03.25 | AstraZeneca Outperform | Bernstein Research | |
03.03.25 | Novo Nordisk Buy | UBS AG | |
03.03.25 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
28.02.25 | Volvo (B) Buy | Deutsche Bank AG | |
27.02.25 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
26.02.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
26.02.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
26.02.25 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
26.02.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
26.02.25 | Volvo (B) Buy | UBS AG | |
25.02.25 | Novo Nordisk Market-Perform | Bernstein Research | |
25.02.25 | Hennes Mauritz (H M, H&M) Equal Weight | Barclays Capital | |
24.02.25 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
24.02.25 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
24.02.25 | Novo Nordisk Buy | UBS AG | |
24.02.25 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
24.02.25 | Volvo (B) Buy | Goldman Sachs Group Inc. | |
20.02.25 | Nokia Overweight | JP Morgan Chase & Co. | |
20.02.25 | AstraZeneca Outperform | Bernstein Research | |
20.02.25 | Novo Nordisk Market-Perform | Bernstein Research | |
20.02.25 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
19.02.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
19.02.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
18.02.25 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
17.02.25 | Novo Nordisk Buy | UBS AG | |
17.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
13.02.25 | AstraZeneca Buy | UBS AG |